ArticleCancer research communications2025

Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer.

Bunpei Isoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.